Post Study Continuation of C7 for G1D
| Status: | Available |
|---|---|
| Healthy: | No |
| Age Range: | Any - 28 |
| Updated: | 4/2/2016 |
| Start Date: | January 2013 |
| End Date: | December 2018 |
| Contact: | Dorothy Kelly, MA |
| Email: | rare.diseases@utsouthwestern.edu |
This protocol provides ongoing access to triheptanoin for patients who did complete an
initial pilot protocol, and provides the opportunity to collect long-term safety data from
patients treated with triheptanoin.
initial pilot protocol, and provides the opportunity to collect long-term safety data from
patients treated with triheptanoin.
Only patients who completed the initial pilot study were eligible. The study is ongoing with
these patients only.
these patients only.
Inclusion Criteria:
- Patients enrolled in the pilot trial (UTSW 122010-186)
Exclusion Criteria:
- Subjects who did not complete the pilot trial (UTSW 122010-186)
We found this trial at
1
site
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
Click here to add this to my saved trials
